Adherence to Biopsy Guidelines for Barrett's Esophagus Surveillance in the Community Setting in the United States

Clinical Gastroenterology and Hepatology

Volumn 7, Issue 7, 2009, Pages 736-742

  Abrams, Julian A ^a,b   Kapel, Robert C ^c   Lindberg, Guy M ^d   Saboorian, Mohammad H ^d   Genta, Robert M ^d,e   Neugut, Alfred I ^a,b   Lightdale, Charles J ^a,b  

^a New York Presbyterian Columbia University Medical Center   (United States)

^b Columbia University ^*  (United States)

^c DANBURY HOSPITAL   (United States)

^d CARIS LIFE SCIENCES   (United States)

^e UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BARRETT ESOPHAGUS; CONTROLLED STUDY; DISEASE SURVEILLANCE; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS BIOPSY; ESOPHAGUS DISEASE; ESOPHAGUS DYSPLASIA; FEMALE; HIATUS HERNIA; HUMAN; HUMAN TISSUE; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; PATIENT COMPLIANCE; PRACTICE GUIDELINE; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; BARRETT ESOPHAGUS; BIOPSY; FEMALE; GUIDELINE ADHERENCE; HEALTH SERVICES RESEARCH; HUMANS; MALE; MIDDLE AGED; UNITED STATES;

EID: 67649398847     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2008.12.027     Document Type: Article

References (45)

1. Kubo A., and Corley D.A. Marked regional variation in adenocarcinomas of the esophagus and the gastric cardia in the United States. Cancer 95 (2002) 2096-2102
2. Pohl H., and Welch H.G. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst 97 (2005) 142-146
3. Shaheen N.J. Advances in Barrett's esophagus and esophageal adenocarcinoma. Gastroenterology 128 (2005) 1554-1566
4. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2007. CA Cancer J Clin 57 (2007) 43-66
5. Ries L.A.G., Melbert D., and Krapcho M. SEER Cancer Statistics Review, 1975-2005 (2008), National Cancer Institute, Bethesda, MD. http://seer.cancer.gov/statfacts/html/esoph.html?statfacts_page=esoph.ht ml&x=14&y=11 Volume, Accessed: May 27, 2008
6. Wang K.K., and Sampliner R.E. Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus. Am J Gastroenterol 103 (2008) 788-797
7. McArdle J.E., Lewin K.J., Randall G., et al. Distribution of dysplasias and early invasive carcinoma in Barrett's esophagus. Hum Pathol 23 (1992) 479-482
8. Jego M., Volant A., Faycal J., et al. Prevalence and topography of intestinal metaplasia in columnar lined esophagus. Gastroenterol Clin Biol 31 (2007) 601-606
9. Cameron A.J., and Carpenter H.A. Barrett's esophagus, high-grade dysplasia, and early adenocarcinoma: a pathological study. Am J Gastroenterol 92 (1997) 586-591
10. Reid B.J., Weinstein W.M., Lewin K.J., et al. Endoscopic biopsy can detect high-grade dysplasia or early adenocarcinoma in Barrett's esophagus without grossly recognizable neoplastic lesions. Gastroenterology 94 (1988) 81-90
11. Peters F.P., Curvers W.L., Rosmolen W.D., et al. Surveillance history of endoscopically treated patients with early Barrett's neoplasia: nonadherence to the Seattle biopsy protocol leads to sampling error. Dis Esophagus 21 (2008) 475-479
12. Abela J.E., Going J.J., Mackenzie J.F., et al. Systematic four-quadrant biopsy detects Barrett's dysplasia in more patients than nonsystematic biopsy. Am J Gastroenterol 103 (2008) 850-855
13. Sampliner R.E. Practice guidelines on the diagnosis, surveillance, and therapy of Barrett's esophagus: the Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol 93 (1998) 1028-1032
14. Streitz Jr. J.M., Andrews Jr. C.W., and Ellis Jr. F.H. Endoscopic surveillance of Barrett's esophagus: does it help?. J Thorac Cardiovasc Surg 105 (1993) 383-388
15. Peters J.H., Clark G.W., Ireland A.P., et al. Outcome of adenocarcinoma arising in Barrett's esophagus in endoscopically surveyed and nonsurveyed patients. J Thorac Cardiovasc Surg 108 (1994) 813-822
16. van Sandick J.W., van Lanschot J.J., Kuiken B.W., et al. Impact of endoscopic biopsy surveillance of Barrett's oesophagus on pathological stage and clinical outcome of Barrett's carcinoma. Gut 43 (1998) 216-222
17. Incarbone R., Bonavina L., Saino G., et al. Outcome of esophageal adenocarcinoma detected during endoscopic biopsy surveillance for Barrett's esophagus. Surg Endosc 16 (2002) 263-266
18. Ferguson M.K., and Durkin A. Long-term survival after esophagectomy for Barrett's adenocarcinoma in endoscopically surveyed and nonsurveyed patients. J Gastrointest Surg 6 (2002) 29-36
19. Corley D.A., Levin T.R., Habel L.A., et al. Surveillance and survival in Barrett's adenocarcinomas: a population-based study. Gastroenterology 122 (2002) 633-640
20. Fountoulakis A., Zafirellis K.D., Dolan K., et al. Effect of surveillance of Barrett's oesophagus on the clinical outcome of oesophageal cancer. Br J Surg 91 (2004) 997-1003
21. Ofman J.J., Shaheen N.J., Desai A.A., et al. The quality of care in Barrett's esophagus: endoscopist and pathologist practices. Am J Gastroenterol 96 (2001) 876-881
22. Das D., Ishaq S., Harrison R., et al. Management of Barrett's esophagus in the UK: overtreated and underbiopsied but improved by the introduction of a national randomized trial. Am J Gastroenterol 103 (2008) 1079-1089
23. Amamra N., Touzet S., Colin C., et al. Current practice compared with the international guidelines: endoscopic surveillance of Barrett's esophagus. J Eval Clin Pract 13 (2007) 789-794
24. Mandal A., Playford R.J., and Wicks A.C. Current practice in surveillance strategy for patients with Barrett's oesophagus in the UK. Aliment Pharmacol Ther 17 (2003) 1319-1324
25. van Sandick J.W., Bartelsman J.F., van Lanschot J.J., et al. Surveillance of Barrett's oesophagus: physicians' practices and review of current guidelines. Eur J Gastroenterol Hepatol 12 (2000) 111-117
26. Falk G.W., Ours T.M., and Richter J.E. Practice patterns for surveillance of Barrett's esophagus in the United States. Gastrointest Endosc 52 (2000) 197-203
27. Sampliner R.E. Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus. Am J Gastroenterol 97 (2002) 1888-1895
28. Weston A.P., Badr A.S., and Hassanein R.S. Prospective multivariate analysis of clinical, endoscopic, and histological factors predictive of the development of Barrett's multifocal high-grade dysplasia or adenocarcinoma. Am J Gastroenterol 94 (1999) 3413-3419
29. Weston A.P., Krmpotich P.T., Cherian R., et al. Prospective long-term endoscopic and histological follow-up of short segment Barrett's esophagus: comparison with traditional long segment Barrett's esophagus. Am J Gastroenterol 92 (1997) 407-413
30. Wong A., and Fitzgerald R.C. Epidemiologic risk factors for Barrett's esophagus and associated adenocarcinoma. Clin Gastroenterol Hepatol 3 (2005) 1-10
31. Cohen J., Safdi M.A., Deal S.E., et al. Quality indicators for esophagogastroduodenoscopy. Am J Gastroenterol 101 (2006) 886-891
32. Montgomery E., Bronner M.P., Goldblum J.R., et al. Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation. Hum Pathol 32 (2001) 368-378
33. Reeves G.K., Pirie K., Beral V., et al. Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ 335 (2007) 1134
34. Merry A.H., Schouten L.J., Goldbohm R.A., et al. Body mass index, height and risk of adenocarcinoma of the oesophagus and gastric cardia: a prospective cohort study. Gut 56 (2007) 1503-1511
35. Corley D.A., Kubo A., Levin T.R., et al. Abdominal obesity and body mass index as risk factors for Barrett's esophagus. Gastroenterology 133 (2007) 34-41 quiz 311
36. Gammon M.D., Schoenberg J.B., Ahsan H., et al. Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst 89 (1997) 1277-1284
37. Weston A.P., Badr A.S., Topalovski M., et al. Prospective evaluation of the prevalence of gastric Helicobacter pylori infection in patients with GERD, Barrett's esophagus, Barrett's dysplasia, and Barrett's adenocarcinoma. Am J Gastroenterol 95 (2000) 387-394
38. Bergman J.J., and Tytgat G.N. New developments in the endoscopic surveillance of Barrett's oesophagus. Gut 54 Suppl 1 (2005) i38-i42
39. Harrison R., Perry I., Haddadin W., et al. Detection of intestinal metaplasia in Barrett's esophagus: an observational comparator study suggests the need for a minimum of eight biopsies. Am J Gastroenterol 102 (2007) 1154-1161
40. Ward E.M., Wolfsen H.C., Achem S.R., et al. Barrett's esophagus is common in older men and women undergoing screening colonoscopy regardless of reflux symptoms. Am J Gastroenterol 101 (2006) 12-17
41. Hirota W.K., Loughney T.M., Lazas D.J., et al. Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: prevalence and clinical data. Gastroenterology 116 (1999) 277-285
42. Rex D.K., Cummings O.W., Shaw M., et al. Screening for Barrett's esophagus in colonoscopy patients with and without heartburn. Gastroenterology 125 (2003) 1670-1677
43. Lee S.J., Joffe S., Artz A.S., et al. Individual physician practice variation in hematopoietic cell transplantation. J Clin Oncol 26 (2008) 2162-2170
44. Abdel-Malek N., Chiarelli A.M., Sloan M., et al. Influence of physician and patient characteristics on adherence to breast cancer screening recommendations. Eur J Cancer Prev 17 (2008) 48-53
45. Hershman D.L., Buono D., McBride R.B., et al. Surgeon characteristics and receipt of adjuvant radiotherapy in women with breast cancer. J Natl Cancer Inst 100 (2008) 199-206